| Product Name |
Lapatinib Inhouse Impurity 8 / Lapatinib Dimer Impurity
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Pharmaceutical Standards, Fine Chemicals |
| CAS No |
N/A |
| Catalog Number |
GS.08.LAP.38 |
| Chemical Name/Synonyms |
N-(4-(3-Fluorobenzyloxy)-3-chlorophenyl)-6-(5-((((5-(4-(4-(3-fluorobenzyloxy)-3-chlorophenylamino)quinazolin-6-yl)furan-2-yl)methyl)(2-(methylsulfonyl)ethyl) amino)methyl)furan-2-yl)quinazolin-4-amine |
| Molecular Weight |
1038.94 |
| Molecular Formula |
C55H43Cl2F2N7O6S |
| Purity |
NLT 95 % |
| Applications |
Lapatinib is used to treat breast cancer, especially metastatic breast cancer that has progressed after trastuzumab treatment and other chemotherapy. |
| Inventory Status |
customized
|
